These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16612159)

  • 1. [Successful chemotherapy with carboplatin and docetaxel for an elderly patient with advanced non-small cell lung cancer].
    Kawashima S; Kawashima T; Kuroda T; Kikkawa K; Nishi Y; Tanabe M; Gotou T; Matsuzawa Y; Shirai K
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):493-5. PubMed ID: 16612159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer.
    Kim HJ; Kim TG; Lee HJ; Kim JH; Lim BH; Seo JW; Kang EM; Lee BU; Ahn YM; Roh YH; Nam SH; Kim BS
    Lung Cancer; 2010 May; 68(2):248-52. PubMed ID: 19647333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advanced non-small cell lung cancer responded to both vinorelbine and carboplatin over long-term outpatient treatment].
    Chohnabayashi N; Uchiyama N; Nishimura N; Nasu H
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1395-8. PubMed ID: 15446564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancer.
    Kaira K; Tsuchiya S; Sunaga N; Yanagitani N; Watanabe S; Imai H; Hisada T; Ishizuka T; Saito R; Mori M
    Am J Clin Oncol; 2007 Feb; 30(1):51-6. PubMed ID: 17278895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of non-small cell lung carcinoma successfully treated with carboplatin and weekly paclitaxel under renal dysfunction].
    Mori M; Takeda E; Sakai K; Nishida Y; Tamura K; Akedo I; Yanagi K; Nakagawa C; Tsugawa M; Ono H; Kubo M
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):2061-4. PubMed ID: 15570941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of carboplatin combined with biweekly docetaxel for advanced non-small cell lung cancer.
    Ishimoto O; Sugawara S; Inoue A; Ishida T; Munakata M; Koinumaru S; Hasegawa Y; Suzuki T; Miki H; Saijo Y; Nukiwa T
    J Thorac Oncol; 2006 Nov; 1(9):979-83. PubMed ID: 17409982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of the docetaxel-carboplatin chemotherapy regimen in advanced non-small-cell lung cancer.
    Tsavaris N; Kosmas C; Skopelitis E; Gennatas K; Zorbala A; Papas P; Gouveris P; Antypas G; Rokana S; Tzelepis G
    Lung; 2005; 183(6):405-16. PubMed ID: 16465600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer.
    Yoshimura N; Kudoh S; Kimura T; Mitsuoka S; Kyoh S; Tochino Y; Asai K; Kodama T; Ichimaru Y; Yana T; Hirata K
    J Thorac Oncol; 2009 Mar; 4(3):371-5. PubMed ID: 19155998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC).
    Jain AK; Hughes RS; Sandler AB; Dowlati A; Schwartzberg LS; Dobbs T; Schlabach L; Wu J; Muldowney NJ; Choy H
    J Thorac Oncol; 2009 Jun; 4(6):722-7. PubMed ID: 19404213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence effect of docetaxel and carboplatin on toxicity, tumor response and pharmacokinetics in non-small-cell lung cancer patients: a phase I study of two sequences.
    Ando M; Saka H; Ando Y; Minami H; Kuzuya T; Yamamoto M; Watanabe A; Sakai S; Shimokata K; Hasegawa Y
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):552-8. PubMed ID: 15856233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer.
    Kosmas C; Tsavaris N; Koutras A; Makatsoris T; Mylonakis N; Tzelepis G; Dimitrakopoulos A; Spyropoulos K; Polyzos A; Karabelis A; Kalofonos HP
    Oncology; 2005; 69(4):333-41. PubMed ID: 16282711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction combination chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer.
    Herse B; Dalichau H; Wörmann B; Hemmerlein B; Schmidberger H; Hess CF; Hannemann P; Criée CP; Hiddemann W; Griesinger F
    Thorac Cardiovasc Surg; 1998 Oct; 46(5):298-302. PubMed ID: 9885122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase I study of docetaxel combined with carboplatin in patients with non-small cell lung cancer].
    Zhu LM; Li QY; Yu XM; Ma SL
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):946-8. PubMed ID: 17533750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study.
    Ramalingam S; Dobbs TW; Einzig AI; Wojtowicz-Praga S; Cascino M; Bonomi P; Belani CP
    Cancer Chemother Pharmacol; 2004 May; 53(5):439-44. PubMed ID: 15132135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of endobronchial squamous cell lung cancer successfully treated with weekly chemotherapy of carboplatin and paclitaxel].
    Kambayashi T; Ri M; Yanagihara K; Miyahara R; Bando T; Hasegawa S; Inui K; Wada H
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):841-4. PubMed ID: 12852353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer.
    William WN; Kies MS; Fossella FV; Liu DD; Gladish G; Tse WH; Lee JJ; Hong WK; Lippman SM; Kim ES
    Cancer; 2010 May; 116(10):2401-8. PubMed ID: 20225327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination chemotherapy with carboplatin and docetaxel for elderly patients with non-small-cell lung cancer].
    Terashima T; Matsuzaki T; Ogawa R; Naitou A; Morishita T; Ishizaka A
    Nihon Kokyuki Gakkai Zasshi; 2008 Jul; 46(7):516-21. PubMed ID: 18700567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter phase II study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer.
    Giannakakis T; Kakolyris S; Theodoropoulos E; Kouroussis C; Michailakis E; Papadouris S; Tsitoura M; Kalbakis K; Souglakos J; Agelaki S; Vardakis N; Georgoulias V
    Anticancer Res; 2002; 22(6B):3743-8. PubMed ID: 12552987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patients.
    Goto Y; Sekine I; Yamada K; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
    J Thorac Oncol; 2008 Apr; 3(4):412-6. PubMed ID: 18379361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel-carboplatin chemotherapy combined with cetuximab in patients with locally advanced or metastatic non small-cell lung cancer (NSCLC)--results of the nonrandomised phase II study TaxErb.
    Fischer JR; Griesinger F; Fink T; Salm T; Marseille A; Wolf M
    Lung Cancer; 2012 Mar; 75(3):348-52. PubMed ID: 21908069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.